Dr Reddys Laboratories Profit & Loss Annual

Trade
BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01023 | Sector: Biotechnology & Drugs
6,045.00 +9.25 (0.15%)Updated : 12 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 28,011.1024,669.7021,545.2019,047.50
Total Revenue 28,011.1024,669.7021,545.2019,047.50
Costof Revenue Total 8,208.708,304.807,997.206,564.70
Gross Profit 19,802.4016,364.9013,548.0012,482.80
Selling/ General/ Admin Expenses Total 11,869.008,204.807,339.906,385.10
Depreciation/ Amortization 1,470.001,250.201,165.201,228.80
Unusual Expense( Income) -152.1069.90930.40676.80
Total Operating Expense 21,395.6019,449.8018,942.7016,402.20
Operating Income 6,615.505,219.902,602.502,645.30
Interest Inc( Exp) Net- Non- Op Total -1,564.003,208.002,813.002,003.00
Other Net 741.90628.9065.7042.10
Net Income Before Taxes 7,201.006,048.503,061.402,883.50
Provisionfor Income Taxes 1,623.101,541.20883.30963.20
Net Income After Taxes 5,577.904,507.302,178.101,920.30
Net Income Before Extra Items 5,577.904,507.302,178.101,920.30
Net Income 5,577.904,507.302,182.501,951.60
Income Availableto Com Excl Extra Ord 5,577.904,507.302,178.101,920.30
Income Availableto Com Incl Extra Ord 5,577.904,507.302,182.501,951.60
Diluted Net Income 5,577.904,507.302,182.501,951.60
Diluted Weighted Average Shares 16.6716.6416.6316.63
Diluted EPS Excluding Extra Ord Items 334.59270.89130.94115.46
DPS- Common Stock Primary Issue 40.0040.0030.0025.00
Diluted Normalized EPS 327.52279.44165.95142.73
Research Development -16,201.0015,100.0015,468.00
Gain( Loss)on Saleof Assets --1,211.001,119.00-42.00
Minority Interest -0.000.000.00
Total Extraordinary Items --4.4031.30
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,370.30+21.05(1.56%)
7,218.95+83.95(1.18%)
2,795.90-37.90 (-1.34%)
2,529.00-26.35 (-1.03%)
HomeMarketsPremiumFor youGet App